paclitaxel
美 [ˌpæklɪ'tæksəl]英 [ˌpæklɪ'tæksəl]
- 网络紫杉醇；太平洋紫杉醇；泰素
paclitaxelpaclitaxel
紫杉醇
紫杉醇（paclitaxel）是靶向抗肿瘤药物紫杉醇（paclitaxel）来源于红豆杉属（Taxusspp）植物，是一种复杂的四环二萜类化合 …
太平洋紫杉醇
继太平洋紫杉醇(Paclitaxel)之后，以半合成方法利用紫杉针叶作为原料制造完成的欧洲紫杉醇(Docetaxel)，它与太平洋紫杉醇 …
泰素
药物如泰素（paclitaxel）和长春花碱（vinblastine）通过诱导Bcl-2磷酸化而使之失活，致使凋亡发生，对AIPC的治疗有一定的 …
紫杉酚
紫杉酚(paclitaxel)，是全世界癌症药物销售量最大的药物之一。它被用于治疗子宫癌和乳腺癌，许多乳腺癌治愈者仍服用该药以 …
紫杉醇脂质体
江苏省医保目录 2010版-药源网 ... 骨化三醇 Calcitriol 紫杉醇脂质体 Paclitaxel 斑蝥酸钠 Disodium Cantharidinate ...
紫杉醇注射液
目前新的化疗药包括吉西他滨（gemcitabin）、长春瑞滨（vinorelbine）、紫杉醇注射液（paclitaxel）等及分别为GP、NP、P…
紫衫醇
西药 ... 重酒石酸长春瑞宾 Vinorelbine Bitartrate 紫衫醇 Paclitaxel 氨鲁米特 Aminoglutethimide ...
紫杉醇晶体
该公司在这项交易中的角色就是要向国家癌症研究所供应17千克高纯度紫杉醇晶体（paclitaxel）（这些晶体还是从别的化学公 …
1
However, sirolimus stents fared better than paclitaxel stents in terms of MI, target vessel revascularization, and late thrombosis.
在心梗、靶血管的血运重建和晚期血栓文面，西罗莫司支架优于紫杉醇支架。
2
They also found that this synergy occurred with trastuzumab and either paclitaxel or vincristine.
他们发现这种协同作用也发生在脂质体和长春新碱或紫杉醇。
3
The total effective rate of acupuncture on the treatment of paclitaxel induced sensory neuropathy is higher than that of oxaliplatin.
针刺治疗紫杉醇引起的感觉神经障碍较奥沙利铂的总有效率高。
4
Stent thrombosis after 1 year was more common with both sirolimus-eluting stents and paclitaxel-eluting stents than with bare-metal stents.
与裸金属支架组相比，1年后雷帕霉素和紫杉醇药物涂层支架组更容易发生血栓。
5
The overall response rate (ORR) tended to be higher with both weekly nab-paclitaxel regimens than docetaxel by independent radiology review.
通过独立的放射学复查，蛋白结合型紫杉醇单周方案的总有效率（ORR）要比紫杉醇高。
6
Animal experiment proved that compound paclitaxel phospholipid dispersing substance improves bioavailability of paclitaxel.
动物试验证实，复方紫杉醇磷脂分散物显著提高了紫杉醇的口服生物利用度。
7
The invention relates to a mutual prodrug and a preparation method thereof based on paclitaxel and nitrogen mustard.
本发明涉及一种基于紫杉醇-氮芥的协同前药及其制备方法。
8
The researchers observe that polymer-based paclitaxel- eluting stents offer superior angiographic and intravascular ultrasound findings.
研究者们观察到聚合物基紫杉醇洗脱支架在血管造影和血管内超声表现出更高优越性。
9
A practical and efficient synthesis of the protected, esterification-ready paclitaxel side chain was established.
为制备保护的预酯化紫杉醇侧链提供了一种有效而又实用的合成方法。
10
CONCLUSION There is significant difference between the tissue distributions of rats after paclitaxel liposome and paclitaxel injection.
结论大鼠给予紫杉醇脂质体及紫杉醇注射液后在各个脏器的分布量几乎均有极显著性差异。
11
The trial compared the effectiveness of Avastin plus carboplatin and paclitaxel with chemotherapy by carboplatin and paclitaxel alone.
试验中用阿瓦斯丁联合卡铂和紫杉醇化疗和单用卡铂和紫杉醇化疗效果进行对比。
12
Objective To evaluate the efficacy and toxicity of nedaplatin combined with paclitaxel in treating advanced esophageal carcinoma.
目的观察紫杉醇联合奈达铂治疗晚期食管癌的有效性和安全性。
13
Objective: On the basis of the national standard, we have studied on bacterial endotoxins test for Paclitaxel Injection.
目的：在现行的国家标准的基础上对紫杉醇注射液细菌内毒素检查法进行再研究。
14
The paclitaxel-coated balloons used in this trial were standard angioplasty balloons.
本试验以紫杉醇涂层球囊为血管成形术球囊标准。
15
Objective: To investigate the effects and mechanism of intravesical instillation of paclitaxel in orthotopic bladder tumor of rats.
目的：探讨紫杉醇连续膀胱灌注对大鼠膀胱肿瘤生长的作用和机制。
16
Key raw material to extract Paclitaxel (prominent ingredient in cancer-fighting medication), no replacement in the market currently.
提取抗癌药物紫杉醇的主要原料，目前尚无替代产品。
17
Objective To investigate the killing effect of liposome encapsulated paclitaxel on endometrial carcinoma Ishikawa cells in vitro.
目的探讨注射用紫杉醇脂质体对人子宫内膜癌细胞系的体外杀伤作用。
18
OBJECTIVE To develop a new preparation of paclitaxel using hyaluronan as the base with high efficacy and low toxicity-ty.
目的开发一种紫杉醇透明质酸的新型高效低毒注射剂。
19
Another 54 people did not receive paclitaxel in any form.
另外54人未接受任何形式的紫杉醇。
20
CASE: A 41-year-old woman with infiltrating ductal carcinoma of the breast was undergoing chemotherapy with paclitaxel and trastuzumab.
案例：41岁女子与浸润性导管癌乳腺是接受化疗紫杉醇和曲妥。
21
Objective To evaluate the efficiency and toxicity of paclitaxel in patients with advanced malignancies.
目的观察以紫杉类为主的联合化疗方案治疗晚期恶性肿瘤的临床疗效及毒副反应。
22
Objective To evaluate the efficacy and toxicity of Paclitaxel and adriamycin(TA) in the treatment of advanced breast cancer.
目的观察紫杉醇联合阿霉素（TA）治疗晚期乳腺癌的疗效和不良反应。
23
Patients received four courses of chemotherapy with paclitaxel, carboplatin, and etoposide, administered at 3-week intervals.
病人接受四个疗程的紫杉醇、卡铂、依托泊苷化学治疗，每个疗程间隔3周。
24
The most commonly used anti-proliferative drugs are paclitaxel and rapamycin, and their derivatives.
目前最常用的抗增生药物为紫杉醇和雷帕霉素及其衍生物。
25
At present, paclitaxel plus carboplatin become the first-line chemotherapeutic regimen of advanced EOC.
紫杉醇加卡铂是晚期EOC的标准一线化疗方案。
26
Objective: To probe the cytotoxic effect of paclitaxel on human osteosarcoma cell line SOSP-9607 and its mechanism.
前言：目的：探讨紫杉醇对成骨肉瘤细胞的杀伤作用及机制。
27
Objective: To inspect the effect of activated carbon with different dosage and temperature on quality of paclitaxel injection.
目的：考察活性炭用量和温度对紫杉醇注射液质量的影响。
28
Objective To evaluate the effects of paclitaxel on growth inhibition of human gastric cancer cells.
目的探讨特素（紫杉醇注射液）在体外对人胃腺癌细胞的增殖抑制效应。
29
New advances in chemotherapy include paclitaxel and docetaxel.
化疗新进展包括紫杉醇和多烯紫杉醇。
30
The expression of MDR-1 might not contribute to acquired Paclitaxel-resistance in nasopharyngeal carcinoma.
MDR-1在鼻咽癌细胞产生获得性紫杉醇耐药的过程中不起主要作用。